|
Mora E, Montoro J, Balaguer A, Rovira M, Cabrero M, Heras I, Ribera JM, Antelo G, Martin AA, Lopez Godino O, Torrent A, Villalba M, Chorao P, Sanz MA, Sanz J; Grupo Espanol de Trasplante Hematopoyetico (GETH). Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia. Bone Marrow Transplant. 2024 Aug;59(8):1137-1145. doi: 10.1038/s41409-024-02298-z. Epub 2024 May 16. PubMed PMID: 38755458.
AÑO: 2024; IF: 5.2
|
38755458
|
Cruz D, Rodriguez-Romanos R, Gonzalez-Bartulos M, Garcia-Cadenas I, de la Camara R, Heras I, Buno I, Santos N, Lloveras N, Velarde P, Tuset E, Martinez C, Gonzalez M, Sanz GF, Ferra C, Sampol A, Coll R, Perez-Simon JA, Lopez-Jimenez J, Jurado M, Gallardo D. LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors. Front Immunol. 2023 Jan 20;14:1066393. doi: 10.3389/fimmu.2023.1066393. eCollection 2023. PubMed PMID: 36742309; PubMed Central PMCID: PMC9897054.
AÑO: 2023; IF: 5.7
|
|
Pinana JL, Heras I, Aiello TF, Garcia-Cadenas I, Vazquez L, Lopez-Jimenez J, Chorao P, Aroca C, Garcia-Vidal C, Arroyo I, Soler-Espejo E, Lopez-Corral L, Avendano-Pita A, Arrufat A, Garcia-Gutierrez V, Arellano E, Hernandez-Medina L, Gonzalez-Santillana C, Morell J, Hernandez-Rivas JA, Rodriguez-Galvez P, Mico-Cerda M, Guerreiro M, Campos D, Navarro D, Cedillo A, Martino R, Solano C; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. Viruses. 2023 Oct 8;15(10):2066. doi: 10.3390/v15102066. PubMed PMID: 37896843; PubMed Central PMCID: PMC10612015.
AÑO: 2023; IF: 3.8
|
|
Bailen R, Alenda R, Herruzo-Delgado B, Acosta-Fleitas C, Valles A, Esquirol A, Fonseca M, Solan L, Sanchez-Vadillo I, Bautista G, Bento L, Lopez-Godino O, Perez-Martinez A, Torrent A, Zanabili J, Calbacho M, Moreno MA, Pascual-Cascon MJ, Guerra-Dominguez L, Chinea A, Garcia-Cadenas I, Lopez-Corral L, Boix-Giner F, Lopez Lorenzo JL, Humala K, Duarte R, Sampol A, Heras I, Vicario JL, Balas A, Oarbeascoa G, Fernandez-Caldas P, Anguita J, Kwon M. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Front Immunol. 2023 May 26;14:1165759. doi: 10.3389/fimmu.2023.1165759. eCollection 2023. PubMed PMID: 37304258; PubMed Central PMCID: PMC10250708.
AÑO: 2023; IF: 5.7
|
|
Ljungman P, Tridello G, Pinana JL, Ciceri F, Sengeloev H, Kulagin A, Mielke S, Yegin ZA, Collin M, Einardottir S, Lepretre SD, Maertens J, Campos A, Metafuni E, Pichler H, Folber F, Solano C, Nicholson E, Yuksel MK, Carlson K, Aguado B, Besley C, Byrne J, Heras I, Dignan F, Kroger N, Robin C, Khan A, Lenhoff S, Grassi A, Dobsinska V, Miranda N, Jimenez MJ, Yonal-Hindilerden I, Wilson K, Averbuch D, Cesaro S, Xhaard A, Knelange N, Styczynski J, Mikulska M, de la Camara R. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry. Front Immunol. 2023 Mar 7;14:1125824. doi: 10.3389/fimmu.2023.1125824. eCollection 2023. PubMed PMID: 36960069; PubMed Central PMCID: PMC10028143.
AÑO: 2023; IF: 5.7
|